Bristol-Myers Squibb (NY:BMY)

57.33 -0.15 (-0.27%)

Streaming Delayed Price Updated: 3:52 PM EDT, Mar 23, 2026 Add to My Watchlist

Price and Volume

Volume	6,719,343
Open	58.22
Bid (Size)	57.32 (700)
Ask (Size)	57.34 (300)
Prev. Close	57.48
Today's Range	57.11 - 58.25
52wk Range	42.52 - 62.89
Shares Outstanding	2,222,113,553
Dividend Yield	4.40%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market

Today 10:13 EDT

In a landmark decision for the dermatology sector, the U.S. Food and Drug Administration (FDA) has officially approved ICOTYDE™ (icotrokinra), a first-of-its-kind oral peptide for the treatment of...

Via MarketMinute

Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)

Today 6:59 EDT

From Bristol Myers Squibb

Via Business Wire

Performance

YTD	+7.2%	+7.2%
1 Month	-5.5%	-5.5%
3 Month	+4.9%	+4.9%
6 Month	+27.4%	+27.4%
1 Year	-6.1%	-6.1%

More News

1 High-Yield Dividend Stock That's Too Cheap to Ignore ↗

March 21, 2026

Via The Motley Fool

Bristol-Myers Squibb Co. (NYSE:BMY): A High-Yield Dividend Stock for Income Investors ↗

March 13, 2026

Via Chartmill

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

March 20, 2026

From Bristol Myers Squibb

Via Business Wire

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

March 19, 2026

From Bristol Myers Squibb

Via Business Wire

AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown

March 18, 2026

Via MarketMinute

Bristol‑Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash ↗

March 18, 2026

Via The Motley Fool

READYSTATE Dumps 361,000 Workiva Shares Worth $32 Million ↗

March 17, 2026

Via The Motley Fool

The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump

March 17, 2026

Via MarketMinute

Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026

March 16, 2026

Via MarketMinute

1 ETF That Could Turn $100 Per Month Into $67,380 ↗

March 15, 2026

Via The Motley Fool

1 S&P 500 Stock Worth Your Attention and 2 We Question

March 12, 2026

Via StockStory

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

Via MarketMinute

3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗

March 10, 2026

Via The Motley Fool

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

March 09, 2026

From Bristol Myers Squibb

Via Business Wire

Why Bristol Myers Squibb Stock Crushed it in February ↗

March 08, 2026

Via The Motley Fool

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis

March 06, 2026

From Bristol Myers Squibb

Via Business Wire

2 Top Healthcare Dividend Stocks to Buy and Hold Forever ↗

March 05, 2026

Via The Motley Fool

Q4 Earnings Outperformers: Bristol-Myers Squibb (NYSE:BMY) And The Rest Of The Branded Pharmaceuticals Stocks

March 04, 2026

Via StockStory

IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook ↗

March 03, 2026

Via Stocktwits

Bristol Myers Squibb Announces Dividend

March 02, 2026

From Bristol Myers Squibb

Via Business Wire

How to Spot Winning Innovation ↗

March 02, 2026

Via The Motley Fool

FourWorld Takes a Major Swing on Sable Offshore (SOC), Buying 8 Million Shares ↗

March 02, 2026

Via The Motley Fool

Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement ↗

February 28, 2026

Via The Motley Fool

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?

Yes, Bristol-Myers Squibb is publicly traded.

What exchange does Bristol-Myers Squibb trade on?

Bristol-Myers Squibb trades on the New York Stock Exchange

What is the ticker symbol for Bristol-Myers Squibb?

The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange

What is the current price of Bristol-Myers Squibb?

The current price of Bristol-Myers Squibb is 57.33

When was Bristol-Myers Squibb last traded?

The last trade of Bristol-Myers Squibb was at 03/23/26 03:52 PM ET

What is the market capitalization of Bristol-Myers Squibb?

The market capitalization of Bristol-Myers Squibb is 127.38B

How many shares of Bristol-Myers Squibb are outstanding?

Bristol-Myers Squibb has 127B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.